nodes	percent_of_prediction	percent_of_DWPC	metapath
Vincristine—ABCC3—Ezetimibe—atherosclerosis	0.0816	0.11	CbGbCtD
Vincristine—ABCB11—Rosuvastatin—atherosclerosis	0.0705	0.0949	CbGbCtD
Vincristine—ABCB11—Pravastatin—atherosclerosis	0.0641	0.0863	CbGbCtD
Vincristine—ABCC1—Rosuvastatin—atherosclerosis	0.0501	0.0674	CbGbCtD
Vincristine—ABCC2—Ezetimibe—atherosclerosis	0.0371	0.0499	CbGbCtD
Vincristine—ABCC2—Simvastatin—atherosclerosis	0.0345	0.0464	CbGbCtD
Vincristine—ABCC2—Lovastatin—atherosclerosis	0.0337	0.0454	CbGbCtD
Vincristine—ABCC2—Pravastatin—atherosclerosis	0.0337	0.0454	CbGbCtD
Vincristine—ABCG2—Rosuvastatin—atherosclerosis	0.0335	0.0451	CbGbCtD
Vincristine—ABCG2—Ezetimibe—atherosclerosis	0.0335	0.0451	CbGbCtD
Vincristine—ABCG2—Pravastatin—atherosclerosis	0.0305	0.041	CbGbCtD
Vincristine—CYP3A7—Simvastatin—atherosclerosis	0.023	0.031	CbGbCtD
Vincristine—CYP3A7-CYP3A51P—Simvastatin—atherosclerosis	0.023	0.031	CbGbCtD
Vincristine—CYP3A7—Lovastatin—atherosclerosis	0.0225	0.0303	CbGbCtD
Vincristine—CYP3A7-CYP3A51P—Lovastatin—atherosclerosis	0.0225	0.0303	CbGbCtD
Vincristine—CYP3A5—Rosuvastatin—atherosclerosis	0.0186	0.025	CbGbCtD
Vincristine—CYP3A5—Simvastatin—atherosclerosis	0.0173	0.0232	CbGbCtD
Vincristine—CYP3A5—Lovastatin—atherosclerosis	0.0169	0.0227	CbGbCtD
Vincristine—CYP3A5—Pravastatin—atherosclerosis	0.0169	0.0227	CbGbCtD
Vincristine—ABCB1—Ezetimibe—atherosclerosis	0.0121	0.0163	CbGbCtD
Vincristine—ABCB1—Simvastatin—atherosclerosis	0.0112	0.0151	CbGbCtD
Vincristine—ABCB1—Pravastatin—atherosclerosis	0.011	0.0148	CbGbCtD
Vincristine—ABCB1—Lovastatin—atherosclerosis	0.011	0.0148	CbGbCtD
Vincristine—CYP3A4—Ezetimibe—atherosclerosis	0.00724	0.00974	CbGbCtD
Vincristine—CYP3A4—Rosuvastatin—atherosclerosis	0.00724	0.00974	CbGbCtD
Vincristine—CYP3A4—Simvastatin—atherosclerosis	0.00673	0.00906	CbGbCtD
Vincristine—CYP3A4—Lovastatin—atherosclerosis	0.00659	0.00886	CbGbCtD
Vincristine—CYP3A4—Pravastatin—atherosclerosis	0.00659	0.00886	CbGbCtD
Vincristine—VIIth nerve paralysis—Lovastatin—atherosclerosis	0.00286	0.0261	CcSEcCtD
Vincristine—VIIth nerve paralysis—Simvastatin—atherosclerosis	0.00268	0.0244	CcSEcCtD
Vincristine—VIIth nerve paralysis—Pravastatin—atherosclerosis	0.00242	0.0221	CcSEcCtD
Vincristine—Drug interaction—Rosuvastatin—atherosclerosis	0.00149	0.0136	CcSEcCtD
Vincristine—Drug interaction—Ezetimibe—atherosclerosis	0.00124	0.0113	CcSEcCtD
Vincristine—Numbness—Pravastatin—atherosclerosis	0.0012	0.0109	CcSEcCtD
Vincristine—TUBB3—connective tissue—atherosclerosis	0.00119	0.0547	CbGeAlD
Vincristine—Musculoskeletal pain—Lovastatin—atherosclerosis	0.00119	0.0108	CcSEcCtD
Vincristine—Drug interaction—Simvastatin—atherosclerosis	0.00118	0.0108	CcSEcCtD
Vincristine—Sensory loss—Pravastatin—atherosclerosis	0.00115	0.0105	CcSEcCtD
Vincristine—Hepatic failure—Rosuvastatin—atherosclerosis	0.00112	0.0102	CcSEcCtD
Vincristine—TUBB6—Pimozide—Ezetimibe—atherosclerosis	0.00112	0.288	CbGdCrCtD
Vincristine—Hyperuricaemia—Niacin—atherosclerosis	0.00109	0.00992	CcSEcCtD
Vincristine—Drug interaction—Pravastatin—atherosclerosis	0.00107	0.00977	CcSEcCtD
Vincristine—Blood uric acid increased—Niacin—atherosclerosis	0.00103	0.00937	CcSEcCtD
Vincristine—Musculoskeletal pain—Pravastatin—atherosclerosis	0.00101	0.00917	CcSEcCtD
Vincristine—Hepatic failure—Lovastatin—atherosclerosis	0.000949	0.00865	CcSEcCtD
Vincristine—TUBB6—Fluvastatin—Rosuvastatin—atherosclerosis	0.000948	0.245	CbGdCrCtD
Vincristine—Neuropathy—Pravastatin—atherosclerosis	0.000932	0.00851	CcSEcCtD
Vincristine—Hepatic failure—Ezetimibe—atherosclerosis	0.00093	0.00849	CcSEcCtD
Vincristine—Urine output increased—Niacin—atherosclerosis	0.000912	0.00832	CcSEcCtD
Vincristine—TUBB6—Simvastatin—Pravastatin—atherosclerosis	0.000906	0.234	CbGdCrCtD
Vincristine—TUBB6—Simvastatin—Lovastatin—atherosclerosis	0.000906	0.234	CbGdCrCtD
Vincristine—TUBA4A—connective tissue—atherosclerosis	0.000905	0.0415	CbGeAlD
Vincristine—TUBB1—adipose tissue—atherosclerosis	0.000894	0.041	CbGeAlD
Vincristine—Hepatic failure—Simvastatin—atherosclerosis	0.000887	0.00809	CcSEcCtD
Vincristine—Muscular weakness—Rosuvastatin—atherosclerosis	0.000887	0.00809	CcSEcCtD
Vincristine—Pain in extremity—Lovastatin—atherosclerosis	0.000852	0.00778	CcSEcCtD
Vincristine—Pain in extremity—Ezetimibe—atherosclerosis	0.000836	0.00763	CcSEcCtD
Vincristine—Polyuria—Niacin—atherosclerosis	0.000834	0.00761	CcSEcCtD
Vincristine—Deafness—Pravastatin—atherosclerosis	0.000806	0.00735	CcSEcCtD
Vincristine—Hepatic failure—Pravastatin—atherosclerosis	0.000802	0.00732	CcSEcCtD
Vincristine—TUBA4A—cardiovascular system—atherosclerosis	0.000787	0.0361	CbGeAlD
Vincristine—Depression—Rosuvastatin—atherosclerosis	0.000773	0.00705	CcSEcCtD
Vincristine—Neuropathy peripheral—Rosuvastatin—atherosclerosis	0.00076	0.00693	CcSEcCtD
Vincristine—Aspartate aminotransferase increased—Ezetimibe—atherosclerosis	0.000753	0.00687	CcSEcCtD
Vincristine—RALBP1—cardiovascular system—atherosclerosis	0.000742	0.0341	CbGeAlD
Vincristine—Muscular weakness—Ezetimibe—atherosclerosis	0.000737	0.00673	CcSEcCtD
Vincristine—TUBB4A—connective tissue—atherosclerosis	0.000725	0.0333	CbGeAlD
Vincristine—Muscular weakness—Simvastatin—atherosclerosis	0.000703	0.00642	CcSEcCtD
Vincristine—TUBB2B—connective tissue—atherosclerosis	0.000701	0.0322	CbGeAlD
Vincristine—Urinary retention—Niacin—atherosclerosis	0.000696	0.00635	CcSEcCtD
Vincristine—TUBA4A—adipose tissue—atherosclerosis	0.000694	0.0319	CbGeAlD
Vincristine—Erectile dysfunction—Lovastatin—atherosclerosis	0.000679	0.00619	CcSEcCtD
Vincristine—Photosensitivity reaction—Lovastatin—atherosclerosis	0.000672	0.00613	CcSEcCtD
Vincristine—Erectile dysfunction—Ezetimibe—atherosclerosis	0.000666	0.00607	CcSEcCtD
Vincristine—TUBB2A—connective tissue—atherosclerosis	0.00066	0.0303	CbGeAlD
Vincristine—Photosensitivity reaction—Ezetimibe—atherosclerosis	0.00066	0.00602	CcSEcCtD
Vincristine—RALBP1—adipose tissue—atherosclerosis	0.000654	0.03	CbGeAlD
Vincristine—Muscular weakness—Niacin—atherosclerosis	0.000646	0.00589	CcSEcCtD
Vincristine—Neuropathy peripheral—Lovastatin—atherosclerosis	0.000644	0.00587	CcSEcCtD
Vincristine—Muscular weakness—Pravastatin—atherosclerosis	0.000636	0.0058	CcSEcCtD
Vincristine—Erectile dysfunction—Simvastatin—atherosclerosis	0.000635	0.00579	CcSEcCtD
Vincristine—Neuropathy peripheral—Ezetimibe—atherosclerosis	0.000632	0.00576	CcSEcCtD
Vincristine—TUBB4A—cardiovascular system—atherosclerosis	0.000631	0.029	CbGeAlD
Vincristine—Photosensitivity reaction—Simvastatin—atherosclerosis	0.000629	0.00574	CcSEcCtD
Vincristine—Depression—Simvastatin—atherosclerosis	0.000613	0.00559	CcSEcCtD
Vincristine—Mental disorder—Rosuvastatin—atherosclerosis	0.00061	0.00556	CcSEcCtD
Vincristine—Neuropathy peripheral—Simvastatin—atherosclerosis	0.000602	0.00549	CcSEcCtD
Vincristine—Erectile dysfunction—Niacin—atherosclerosis	0.000583	0.00532	CcSEcCtD
Vincristine—Dysuria—Pravastatin—atherosclerosis	0.000583	0.00531	CcSEcCtD
Vincristine—Erectile dysfunction—Pravastatin—atherosclerosis	0.000574	0.00523	CcSEcCtD
Vincristine—Photosensitivity reaction—Pravastatin—atherosclerosis	0.000569	0.00519	CcSEcCtD
Vincristine—Connective tissue disorder—Ezetimibe—atherosclerosis	0.000568	0.00519	CcSEcCtD
Vincristine—TUBB6—cardiovascular system—atherosclerosis	0.000566	0.026	CbGeAlD
Vincristine—TUBB4B—connective tissue—atherosclerosis	0.000566	0.026	CbGeAlD
Vincristine—Weight decreased—Pravastatin—atherosclerosis	0.000564	0.00514	CcSEcCtD
Vincristine—Depression—Pravastatin—atherosclerosis	0.000554	0.00505	CcSEcCtD
Vincristine—Stomatitis—Niacin—atherosclerosis	0.00055	0.00502	CcSEcCtD
Vincristine—Acute coronary syndrome—Pravastatin—atherosclerosis	0.000548	0.005	CcSEcCtD
Vincristine—Myocardial infarction—Pravastatin—atherosclerosis	0.000545	0.00497	CcSEcCtD
Vincristine—Neuropathy peripheral—Pravastatin—atherosclerosis	0.000545	0.00497	CcSEcCtD
Vincristine—Sweating—Niacin—atherosclerosis	0.000541	0.00493	CcSEcCtD
Vincristine—TUBB2B—adipose tissue—atherosclerosis	0.000538	0.0247	CbGeAlD
Vincristine—Angiopathy—Ezetimibe—atherosclerosis	0.000525	0.00479	CcSEcCtD
Vincristine—Mediastinal disorder—Ezetimibe—atherosclerosis	0.000521	0.00476	CcSEcCtD
Vincristine—Alopecia—Lovastatin—atherosclerosis	0.000521	0.00475	CcSEcCtD
Vincristine—Myalgia—Rosuvastatin—atherosclerosis	0.000516	0.0047	CcSEcCtD
Vincristine—Alopecia—Ezetimibe—atherosclerosis	0.000511	0.00466	CcSEcCtD
Vincristine—TUBB—adipose tissue—atherosclerosis	0.000509	0.0234	CbGeAlD
Vincristine—Mental disorder—Ezetimibe—atherosclerosis	0.000507	0.00462	CcSEcCtD
Vincristine—TUBB2A—adipose tissue—atherosclerosis	0.000506	0.0232	CbGeAlD
Vincristine—Hypoaesthesia—Niacin—atherosclerosis	0.000504	0.0046	CcSEcCtD
Vincristine—TUBB6—adipose tissue—atherosclerosis	0.000499	0.0229	CbGeAlD
Vincristine—Back pain—Lovastatin—atherosclerosis	0.000497	0.00453	CcSEcCtD
Vincristine—Hypoaesthesia—Pravastatin—atherosclerosis	0.000496	0.00453	CcSEcCtD
Vincristine—TUBB4B—cardiovascular system—atherosclerosis	0.000492	0.0226	CbGeAlD
Vincristine—Infection—Rosuvastatin—atherosclerosis	0.000491	0.00448	CcSEcCtD
Vincristine—SLC22A3—connective tissue—atherosclerosis	0.000487	0.0224	CbGeAlD
Vincristine—Alopecia—Simvastatin—atherosclerosis	0.000487	0.00445	CcSEcCtD
Vincristine—Back pain—Ezetimibe—atherosclerosis	0.000487	0.00444	CcSEcCtD
Vincristine—TUBA4A—liver—atherosclerosis	0.000487	0.0223	CbGeAlD
Vincristine—Nervous system disorder—Rosuvastatin—atherosclerosis	0.000485	0.00442	CcSEcCtD
Vincristine—ABCB11—liver—atherosclerosis	0.000484	0.0222	CbGeAlD
Vincristine—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.000484	0.00442	CcSEcCtD
Vincristine—Mental disorder—Simvastatin—atherosclerosis	0.000483	0.00441	CcSEcCtD
Vincristine—CYP3A7—liver—atherosclerosis	0.000474	0.0217	CbGeAlD
Vincristine—Anaemia—Ezetimibe—atherosclerosis	0.000465	0.00425	CcSEcCtD
Vincristine—Cardiac disorder—Pravastatin—atherosclerosis	0.000463	0.00422	CcSEcCtD
Vincristine—Vertigo—Lovastatin—atherosclerosis	0.000461	0.00421	CcSEcCtD
Vincristine—Angiopathy—Niacin—atherosclerosis	0.00046	0.00419	CcSEcCtD
Vincristine—Leukopenia—Lovastatin—atherosclerosis	0.000459	0.00419	CcSEcCtD
Vincristine—RALBP1—liver—atherosclerosis	0.000459	0.0211	CbGeAlD
Vincristine—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.00045	0.00411	CcSEcCtD
Vincristine—Alopecia—Niacin—atherosclerosis	0.000448	0.00408	CcSEcCtD
Vincristine—Insomnia—Rosuvastatin—atherosclerosis	0.000447	0.00408	CcSEcCtD
Vincristine—Paraesthesia—Rosuvastatin—atherosclerosis	0.000444	0.00405	CcSEcCtD
Vincristine—Anaemia—Simvastatin—atherosclerosis	0.000444	0.00405	CcSEcCtD
Vincristine—Alopecia—Pravastatin—atherosclerosis	0.000441	0.00402	CcSEcCtD
Vincristine—ABCC3—adipose tissue—atherosclerosis	0.000439	0.0202	CbGeAlD
Vincristine—ABCC10—adipose tissue—atherosclerosis	0.000437	0.0201	CbGeAlD
Vincristine—Myalgia—Lovastatin—atherosclerosis	0.000437	0.00399	CcSEcCtD
Vincristine—Hypertension—Ezetimibe—atherosclerosis	0.000435	0.00397	CcSEcCtD
Vincristine—TUBB4B—adipose tissue—atherosclerosis	0.000434	0.0199	CbGeAlD
Vincristine—Vertigo—Simvastatin—atherosclerosis	0.000431	0.00394	CcSEcCtD
Vincristine—Leukopenia—Simvastatin—atherosclerosis	0.00043	0.00392	CcSEcCtD
Vincristine—Myalgia—Ezetimibe—atherosclerosis	0.000429	0.00391	CcSEcCtD
Vincristine—Constipation—Rosuvastatin—atherosclerosis	0.000423	0.00386	CcSEcCtD
Vincristine—Pain—Rosuvastatin—atherosclerosis	0.000423	0.00386	CcSEcCtD
Vincristine—Anaphylactic shock—Lovastatin—atherosclerosis	0.000419	0.00382	CcSEcCtD
Vincristine—Infection—Lovastatin—atherosclerosis	0.000416	0.0038	CcSEcCtD
Vincristine—Anaphylactic shock—Ezetimibe—atherosclerosis	0.000411	0.00375	CcSEcCtD
Vincristine—Thrombocytopenia—Lovastatin—atherosclerosis	0.00041	0.00374	CcSEcCtD
Vincristine—Myalgia—Simvastatin—atherosclerosis	0.000409	0.00373	CcSEcCtD
Vincristine—Infection—Ezetimibe—atherosclerosis	0.000408	0.00372	CcSEcCtD
Vincristine—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000404	0.00369	CcSEcCtD
Vincristine—Nervous system disorder—Ezetimibe—atherosclerosis	0.000403	0.00368	CcSEcCtD
Vincristine—CYP3A7-CYP3A51P—liver—atherosclerosis	0.000403	0.0185	CbGeAlD
Vincristine—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000402	0.00367	CcSEcCtD
Vincristine—Anaemia—Pravastatin—atherosclerosis	0.000401	0.00366	CcSEcCtD
Vincristine—Anorexia—Lovastatin—atherosclerosis	0.000399	0.00364	CcSEcCtD
Vincristine—Vertigo—Niacin—atherosclerosis	0.000396	0.00361	CcSEcCtD
Vincristine—Leukopenia—Niacin—atherosclerosis	0.000395	0.0036	CcSEcCtD
Vincristine—Anaphylactic shock—Simvastatin—atherosclerosis	0.000392	0.00357	CcSEcCtD
Vincristine—Oedema—Simvastatin—atherosclerosis	0.000392	0.00357	CcSEcCtD
Vincristine—Abdominal pain—Rosuvastatin—atherosclerosis	0.000391	0.00357	CcSEcCtD
Vincristine—TUBB4A—liver—atherosclerosis	0.00039	0.0179	CbGeAlD
Vincristine—Vertigo—Pravastatin—atherosclerosis	0.00039	0.00356	CcSEcCtD
Vincristine—Infection—Simvastatin—atherosclerosis	0.000389	0.00355	CcSEcCtD
Vincristine—Leukopenia—Pravastatin—atherosclerosis	0.000389	0.00354	CcSEcCtD
Vincristine—Thrombocytopenia—Simvastatin—atherosclerosis	0.000384	0.0035	CcSEcCtD
Vincristine—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000382	0.00348	CcSEcCtD
Vincristine—Insomnia—Lovastatin—atherosclerosis	0.000379	0.00346	CcSEcCtD
Vincristine—Paraesthesia—Lovastatin—atherosclerosis	0.000376	0.00343	CcSEcCtD
Vincristine—Myalgia—Niacin—atherosclerosis	0.000375	0.00342	CcSEcCtD
Vincristine—Hypertension—Pravastatin—atherosclerosis	0.000375	0.00342	CcSEcCtD
Vincristine—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000374	0.00342	CcSEcCtD
Vincristine—SLC22A3—adipose tissue—atherosclerosis	0.000374	0.0172	CbGeAlD
Vincristine—Anorexia—Simvastatin—atherosclerosis	0.000374	0.00341	CcSEcCtD
Vincristine—Insomnia—Ezetimibe—atherosclerosis	0.000372	0.00339	CcSEcCtD
Vincristine—Myalgia—Pravastatin—atherosclerosis	0.00037	0.00337	CcSEcCtD
Vincristine—Paraesthesia—Ezetimibe—atherosclerosis	0.000369	0.00337	CcSEcCtD
Vincristine—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000364	0.00332	CcSEcCtD
Vincristine—Decreased appetite—Lovastatin—atherosclerosis	0.000364	0.00332	CcSEcCtD
Vincristine—Fatigue—Lovastatin—atherosclerosis	0.000361	0.0033	CcSEcCtD
Vincristine—Oedema—Niacin—atherosclerosis	0.00036	0.00328	CcSEcCtD
Vincristine—Anaphylactic shock—Niacin—atherosclerosis	0.00036	0.00328	CcSEcCtD
Vincristine—Pain—Lovastatin—atherosclerosis	0.000358	0.00327	CcSEcCtD
Vincristine—Constipation—Lovastatin—atherosclerosis	0.000358	0.00327	CcSEcCtD
Vincristine—Decreased appetite—Ezetimibe—atherosclerosis	0.000357	0.00326	CcSEcCtD
Vincristine—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000357	0.00326	CcSEcCtD
Vincristine—TUBB—liver—atherosclerosis	0.000357	0.0164	CbGeAlD
Vincristine—TUBB2A—liver—atherosclerosis	0.000355	0.0163	CbGeAlD
Vincristine—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000355	0.00324	CcSEcCtD
Vincristine—Asthenia—Rosuvastatin—atherosclerosis	0.000355	0.00324	CcSEcCtD
Vincristine—Insomnia—Simvastatin—atherosclerosis	0.000354	0.00323	CcSEcCtD
Vincristine—Oedema—Pravastatin—atherosclerosis	0.000354	0.00323	CcSEcCtD
Vincristine—Anaphylactic shock—Pravastatin—atherosclerosis	0.000354	0.00323	CcSEcCtD
Vincristine—Fatigue—Ezetimibe—atherosclerosis	0.000354	0.00323	CcSEcCtD
Vincristine—Infection—Pravastatin—atherosclerosis	0.000352	0.00321	CcSEcCtD
Vincristine—Paraesthesia—Simvastatin—atherosclerosis	0.000352	0.00321	CcSEcCtD
Vincristine—Pain—Ezetimibe—atherosclerosis	0.000351	0.00321	CcSEcCtD
Vincristine—Constipation—Ezetimibe—atherosclerosis	0.000351	0.00321	CcSEcCtD
Vincristine—TUBB6—liver—atherosclerosis	0.00035	0.0161	CbGeAlD
Vincristine—Hyperhidrosis—Niacin—atherosclerosis	0.000348	0.00317	CcSEcCtD
Vincristine—Thrombocytopenia—Pravastatin—atherosclerosis	0.000347	0.00316	CcSEcCtD
Vincristine—Anorexia—Niacin—atherosclerosis	0.000343	0.00313	CcSEcCtD
Vincristine—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000343	0.00313	CcSEcCtD
Vincristine—Hyperhidrosis—Pravastatin—atherosclerosis	0.000342	0.00312	CcSEcCtD
Vincristine—Decreased appetite—Simvastatin—atherosclerosis	0.000341	0.00311	CcSEcCtD
Vincristine—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000338	0.00309	CcSEcCtD
Vincristine—Diarrhoea—Rosuvastatin—atherosclerosis	0.000338	0.00309	CcSEcCtD
Vincristine—Fatigue—Simvastatin—atherosclerosis	0.000338	0.00308	CcSEcCtD
Vincristine—Anorexia—Pravastatin—atherosclerosis	0.000338	0.00308	CcSEcCtD
Vincristine—Hypotension—Niacin—atherosclerosis	0.000336	0.00307	CcSEcCtD
Vincristine—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000336	0.00307	CcSEcCtD
Vincristine—Constipation—Simvastatin—atherosclerosis	0.000335	0.00306	CcSEcCtD
Vincristine—Pain—Simvastatin—atherosclerosis	0.000335	0.00306	CcSEcCtD
Vincristine—Body temperature increased—Lovastatin—atherosclerosis	0.000331	0.00302	CcSEcCtD
Vincristine—Abdominal pain—Lovastatin—atherosclerosis	0.000331	0.00302	CcSEcCtD
Vincristine—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000328	0.00299	CcSEcCtD
Vincristine—Dizziness—Rosuvastatin—atherosclerosis	0.000327	0.00298	CcSEcCtD
Vincristine—Insomnia—Niacin—atherosclerosis	0.000325	0.00297	CcSEcCtD
Vincristine—Abdominal pain—Ezetimibe—atherosclerosis	0.000325	0.00296	CcSEcCtD
Vincristine—Body temperature increased—Ezetimibe—atherosclerosis	0.000325	0.00296	CcSEcCtD
Vincristine—Paraesthesia—Niacin—atherosclerosis	0.000323	0.00295	CcSEcCtD
Vincristine—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000323	0.00294	CcSEcCtD
Vincristine—ABCB1—blood vessel—atherosclerosis	0.000321	0.0147	CbGeAlD
Vincristine—Gastrointestinal pain—Simvastatin—atherosclerosis	0.00032	0.00292	CcSEcCtD
Vincristine—Insomnia—Pravastatin—atherosclerosis	0.00032	0.00292	CcSEcCtD
Vincristine—Paraesthesia—Pravastatin—atherosclerosis	0.000318	0.0029	CcSEcCtD
Vincristine—Decreased appetite—Niacin—atherosclerosis	0.000313	0.00285	CcSEcCtD
Vincristine—Rash—Rosuvastatin—atherosclerosis	0.000312	0.00284	CcSEcCtD
Vincristine—Dermatitis—Rosuvastatin—atherosclerosis	0.000311	0.00284	CcSEcCtD
Vincristine—Gastrointestinal disorder—Niacin—atherosclerosis	0.000311	0.00283	CcSEcCtD
Vincristine—Body temperature increased—Simvastatin—atherosclerosis	0.00031	0.00283	CcSEcCtD
Vincristine—Abdominal pain—Simvastatin—atherosclerosis	0.00031	0.00283	CcSEcCtD
Vincristine—Headache—Rosuvastatin—atherosclerosis	0.00031	0.00283	CcSEcCtD
Vincristine—ABCC1—adipose tissue—atherosclerosis	0.000309	0.0142	CbGeAlD
Vincristine—Hypersensitivity—Lovastatin—atherosclerosis	0.000309	0.00282	CcSEcCtD
Vincristine—ABCC3—liver—atherosclerosis	0.000308	0.0141	CbGeAlD
Vincristine—Decreased appetite—Pravastatin—atherosclerosis	0.000308	0.00281	CcSEcCtD
Vincristine—Pain—Niacin—atherosclerosis	0.000308	0.00281	CcSEcCtD
Vincristine—ABCC10—liver—atherosclerosis	0.000307	0.0141	CbGeAlD
Vincristine—Fatigue—Pravastatin—atherosclerosis	0.000305	0.00279	CcSEcCtD
Vincristine—TUBB4B—liver—atherosclerosis	0.000304	0.014	CbGeAlD
Vincristine—Pain—Pravastatin—atherosclerosis	0.000303	0.00276	CcSEcCtD
Vincristine—Constipation—Pravastatin—atherosclerosis	0.000303	0.00276	CcSEcCtD
Vincristine—Hypersensitivity—Ezetimibe—atherosclerosis	0.000303	0.00276	CcSEcCtD
Vincristine—Asthenia—Lovastatin—atherosclerosis	0.000301	0.00274	CcSEcCtD
Vincristine—Asthenia—Ezetimibe—atherosclerosis	0.000295	0.00269	CcSEcCtD
Vincristine—Gastrointestinal pain—Niacin—atherosclerosis	0.000294	0.00268	CcSEcCtD
Vincristine—Nausea—Rosuvastatin—atherosclerosis	0.000294	0.00268	CcSEcCtD
Vincristine—Gastrointestinal pain—Pravastatin—atherosclerosis	0.00029	0.00264	CcSEcCtD
Vincristine—Hypersensitivity—Simvastatin—atherosclerosis	0.000289	0.00263	CcSEcCtD
Vincristine—Diarrhoea—Lovastatin—atherosclerosis	0.000287	0.00262	CcSEcCtD
Vincristine—Body temperature increased—Niacin—atherosclerosis	0.000284	0.00259	CcSEcCtD
Vincristine—Abdominal pain—Niacin—atherosclerosis	0.000284	0.00259	CcSEcCtD
Vincristine—Asthenia—Simvastatin—atherosclerosis	0.000281	0.00256	CcSEcCtD
Vincristine—Diarrhoea—Ezetimibe—atherosclerosis	0.000281	0.00256	CcSEcCtD
Vincristine—Abdominal pain—Pravastatin—atherosclerosis	0.00028	0.00255	CcSEcCtD
Vincristine—Body temperature increased—Pravastatin—atherosclerosis	0.00028	0.00255	CcSEcCtD
Vincristine—Dizziness—Lovastatin—atherosclerosis	0.000277	0.00253	CcSEcCtD
Vincristine—Dizziness—Ezetimibe—atherosclerosis	0.000272	0.00248	CcSEcCtD
Vincristine—Diarrhoea—Simvastatin—atherosclerosis	0.000268	0.00245	CcSEcCtD
Vincristine—Vomiting—Lovastatin—atherosclerosis	0.000266	0.00243	CcSEcCtD
Vincristine—Hypersensitivity—Niacin—atherosclerosis	0.000265	0.00242	CcSEcCtD
Vincristine—Rash—Lovastatin—atherosclerosis	0.000264	0.00241	CcSEcCtD
Vincristine—Dermatitis—Lovastatin—atherosclerosis	0.000264	0.00241	CcSEcCtD
Vincristine—Headache—Lovastatin—atherosclerosis	0.000262	0.00239	CcSEcCtD
Vincristine—SLC22A3—liver—atherosclerosis	0.000262	0.012	CbGeAlD
Vincristine—Vomiting—Ezetimibe—atherosclerosis	0.000261	0.00238	CcSEcCtD
Vincristine—Hypersensitivity—Pravastatin—atherosclerosis	0.000261	0.00238	CcSEcCtD
Vincristine—Dizziness—Simvastatin—atherosclerosis	0.000259	0.00236	CcSEcCtD
Vincristine—Rash—Ezetimibe—atherosclerosis	0.000259	0.00236	CcSEcCtD
Vincristine—Dermatitis—Ezetimibe—atherosclerosis	0.000259	0.00236	CcSEcCtD
Vincristine—Asthenia—Niacin—atherosclerosis	0.000258	0.00236	CcSEcCtD
Vincristine—Headache—Ezetimibe—atherosclerosis	0.000257	0.00235	CcSEcCtD
Vincristine—ABCG2—adipose tissue—atherosclerosis	0.000256	0.0117	CbGeAlD
Vincristine—Asthenia—Pravastatin—atherosclerosis	0.000254	0.00232	CcSEcCtD
Vincristine—Vomiting—Simvastatin—atherosclerosis	0.000249	0.00227	CcSEcCtD
Vincristine—Nausea—Lovastatin—atherosclerosis	0.000249	0.00227	CcSEcCtD
Vincristine—Rash—Simvastatin—atherosclerosis	0.000247	0.00225	CcSEcCtD
Vincristine—Dermatitis—Simvastatin—atherosclerosis	0.000247	0.00225	CcSEcCtD
Vincristine—Diarrhoea—Niacin—atherosclerosis	0.000246	0.00225	CcSEcCtD
Vincristine—ABCC2—liver—atherosclerosis	0.000246	0.0113	CbGeAlD
Vincristine—Headache—Simvastatin—atherosclerosis	0.000245	0.00224	CcSEcCtD
Vincristine—Nausea—Ezetimibe—atherosclerosis	0.000244	0.00223	CcSEcCtD
Vincristine—Diarrhoea—Pravastatin—atherosclerosis	0.000242	0.00221	CcSEcCtD
Vincristine—Dizziness—Niacin—atherosclerosis	0.000238	0.00217	CcSEcCtD
Vincristine—CYP3A5—adipose tissue—atherosclerosis	0.000238	0.0109	CbGeAlD
Vincristine—Dizziness—Pravastatin—atherosclerosis	0.000234	0.00214	CcSEcCtD
Vincristine—Nausea—Simvastatin—atherosclerosis	0.000233	0.00212	CcSEcCtD
Vincristine—Vomiting—Niacin—atherosclerosis	0.000229	0.00209	CcSEcCtD
Vincristine—Rash—Niacin—atherosclerosis	0.000227	0.00207	CcSEcCtD
Vincristine—Dermatitis—Niacin—atherosclerosis	0.000227	0.00207	CcSEcCtD
Vincristine—Headache—Niacin—atherosclerosis	0.000225	0.00206	CcSEcCtD
Vincristine—Vomiting—Pravastatin—atherosclerosis	0.000225	0.00205	CcSEcCtD
Vincristine—Rash—Pravastatin—atherosclerosis	0.000223	0.00204	CcSEcCtD
Vincristine—Dermatitis—Pravastatin—atherosclerosis	0.000223	0.00204	CcSEcCtD
Vincristine—Headache—Pravastatin—atherosclerosis	0.000222	0.00202	CcSEcCtD
Vincristine—ABCC1—liver—atherosclerosis	0.000217	0.00995	CbGeAlD
Vincristine—Nausea—Niacin—atherosclerosis	0.000214	0.00195	CcSEcCtD
Vincristine—Nausea—Pravastatin—atherosclerosis	0.00021	0.00192	CcSEcCtD
Vincristine—ABCG2—liver—atherosclerosis	0.00018	0.00824	CbGeAlD
Vincristine—CYP3A5—liver—atherosclerosis	0.000167	0.00765	CbGeAlD
Vincristine—ABCB1—cardiovascular system—atherosclerosis	0.000143	0.00657	CbGeAlD
Vincristine—ABCB1—adipose tissue—atherosclerosis	0.000126	0.00579	CbGeAlD
Vincristine—CYP3A4—liver—atherosclerosis	0.000125	0.00574	CbGeAlD
Vincristine—ABCB1—liver—atherosclerosis	8.85e-05	0.00406	CbGeAlD
Vincristine—ABCC3—Metabolism—GPX1—atherosclerosis	1.04e-05	8.56e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—LDLRAP1—atherosclerosis	1.04e-05	8.51e-05	CbGpPWpGaD
Vincristine—ABCG2—Transmembrane transport of small molecules—ALB—atherosclerosis	1.03e-05	8.48e-05	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—PPARA—atherosclerosis	1.03e-05	8.43e-05	CbGpPWpGaD
Vincristine—NR0B1—Gene Expression—AKT1—atherosclerosis	1.02e-05	8.41e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—FABP4—atherosclerosis	1.02e-05	8.37e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—LCAT—atherosclerosis	1.02e-05	8.37e-05	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—TGFB1—atherosclerosis	1.02e-05	8.37e-05	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—CD36—atherosclerosis	1.01e-05	8.34e-05	CbGpPWpGaD
Vincristine—ABCB1—Transmembrane transport of small molecules—PLG—atherosclerosis	1.01e-05	8.27e-05	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—PLA2G1B—atherosclerosis	1e-05	8.25e-05	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—MTHFR—atherosclerosis	1e-05	8.24e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—APOA4—atherosclerosis	1e-05	8.22e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—LPL—atherosclerosis	9.99e-06	8.21e-05	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—AGT—atherosclerosis	9.94e-06	8.17e-05	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—PPARA—atherosclerosis	9.84e-06	8.08e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—CYP7A1—atherosclerosis	9.82e-06	8.07e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—PLTP—atherosclerosis	9.74e-06	8e-05	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—APOE—atherosclerosis	9.74e-06	8e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—PRKCG—atherosclerosis	9.71e-06	7.98e-05	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—ALOX5—atherosclerosis	9.7e-06	7.97e-05	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—atherosclerosis	9.68e-06	7.96e-05	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—CAV1—atherosclerosis	9.65e-06	7.93e-05	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—APOA1—atherosclerosis	9.63e-06	7.91e-05	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—MTHFR—atherosclerosis	9.61e-06	7.9e-05	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—AGT—atherosclerosis	9.53e-06	7.83e-05	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—PPARA—atherosclerosis	9.43e-06	7.75e-05	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—ABCA1—atherosclerosis	9.38e-06	7.71e-05	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—APOE—atherosclerosis	9.34e-06	7.67e-05	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—ABCA1—atherosclerosis	9.3e-06	7.64e-05	CbGpPWpGaD
Vincristine—ABCB1—Transmembrane transport of small molecules—HMOX1—atherosclerosis	9.29e-06	7.64e-05	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—CAV1—atherosclerosis	9.25e-06	7.6e-05	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—APOA1—atherosclerosis	9.23e-06	7.58e-05	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—atherosclerosis	9.16e-06	7.53e-05	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—HMOX1—atherosclerosis	9.15e-06	7.52e-05	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—AGT—atherosclerosis	9.13e-06	7.51e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—CYP27A1—atherosclerosis	9.08e-06	7.46e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—MTHFR—atherosclerosis	8.99e-06	7.39e-05	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—APOE—atherosclerosis	8.95e-06	7.35e-05	CbGpPWpGaD
Vincristine—ABCB1—Transmembrane transport of small molecules—APOB—atherosclerosis	8.9e-06	7.31e-05	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—atherosclerosis	8.89e-06	7.3e-05	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—CAV1—atherosclerosis	8.87e-06	7.29e-05	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—APOA1—atherosclerosis	8.85e-06	7.27e-05	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—PIK3CG—atherosclerosis	8.79e-06	7.22e-05	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—APOB—atherosclerosis	8.76e-06	7.2e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—PDGFB—atherosclerosis	8.75e-06	7.19e-05	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—NAMPT—atherosclerosis	8.7e-06	7.15e-05	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—LIPC—atherosclerosis	8.64e-06	7.1e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—APOA2—atherosclerosis	8.61e-06	7.07e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—PLA2G2A—atherosclerosis	8.61e-06	7.07e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—ALOX15—atherosclerosis	8.61e-06	7.07e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—ALOX5AP—atherosclerosis	8.61e-06	7.07e-05	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—APOC3—atherosclerosis	8.59e-06	7.06e-05	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—LDLR—atherosclerosis	8.54e-06	7.02e-05	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—GSTM1—atherosclerosis	8.52e-06	7e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—ABCG5—atherosclerosis	8.5e-06	6.99e-05	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—PPARG—atherosclerosis	8.48e-06	6.97e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—LTA4H—atherosclerosis	8.44e-06	6.94e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—ABCG8—atherosclerosis	8.44e-06	6.94e-05	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—PIK3CG—atherosclerosis	8.42e-06	6.92e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—APOE—atherosclerosis	8.37e-06	6.88e-05	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—LPL—atherosclerosis	8.37e-06	6.88e-05	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—CETP—atherosclerosis	8.34e-06	6.85e-05	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—INS—atherosclerosis	8.32e-06	6.84e-05	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—atherosclerosis	8.3e-06	6.82e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—CAV1—atherosclerosis	8.3e-06	6.82e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—APOA1—atherosclerosis	8.28e-06	6.8e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—LPA—atherosclerosis	8.21e-06	6.75e-05	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—GPX1—atherosclerosis	8.16e-06	6.71e-05	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—PPARG—atherosclerosis	8.13e-06	6.68e-05	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—PIK3CG—atherosclerosis	8.08e-06	6.64e-05	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—HMOX1—atherosclerosis	8.05e-06	6.61e-05	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—SCARB1—atherosclerosis	7.99e-06	6.56e-05	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—HMOX1—atherosclerosis	7.98e-06	6.56e-05	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—INS—atherosclerosis	7.97e-06	6.55e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—BGN—atherosclerosis	7.95e-06	6.53e-05	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—CD36—atherosclerosis	7.95e-06	6.53e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—APOA5—atherosclerosis	7.87e-06	6.47e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—NOS2—atherosclerosis	7.8e-06	6.41e-05	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—PPARG—atherosclerosis	7.8e-06	6.41e-05	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—APOB—atherosclerosis	7.71e-06	6.34e-05	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—IL6—atherosclerosis	7.67e-06	6.31e-05	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—INS—atherosclerosis	7.65e-06	6.28e-05	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—APOB—atherosclerosis	7.64e-06	6.28e-05	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—ALB—atherosclerosis	7.63e-06	6.27e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—PLA2G1B—atherosclerosis	7.58e-06	6.23e-05	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—HMGCR—atherosclerosis	7.54e-06	6.2e-05	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—MTHFR—atherosclerosis	7.53e-06	6.19e-05	CbGpPWpGaD
Vincristine—ABCB1—Transmembrane transport of small molecules—PPARA—atherosclerosis	7.51e-06	6.17e-05	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—GSTM1—atherosclerosis	7.5e-06	6.16e-05	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—GSTM1—atherosclerosis	7.43e-06	6.11e-05	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—PPARA—atherosclerosis	7.39e-06	6.07e-05	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—LPL—atherosclerosis	7.36e-06	6.05e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—ALOX5—atherosclerosis	7.32e-06	6.01e-05	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—ALB—atherosclerosis	7.31e-06	6.01e-05	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—LPL—atherosclerosis	7.3e-06	6e-05	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—NOS3—atherosclerosis	7.29e-06	5.99e-05	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—GPX1—atherosclerosis	7.18e-06	5.9e-05	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—AGT—atherosclerosis	7.16e-06	5.88e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—INS—atherosclerosis	7.15e-06	5.88e-05	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—GPX1—atherosclerosis	7.12e-06	5.85e-05	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—AKT1—atherosclerosis	7.08e-06	5.82e-05	CbGpPWpGaD
Vincristine—ABCB1—Transmembrane transport of small molecules—APOA1—atherosclerosis	7.04e-06	5.79e-05	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—APOE—atherosclerosis	7.01e-06	5.76e-05	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—ALB—atherosclerosis	7.01e-06	5.76e-05	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—CD36—atherosclerosis	6.99e-06	5.75e-05	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—NOS3—atherosclerosis	6.99e-06	5.75e-05	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—CAV1—atherosclerosis	6.95e-06	5.71e-05	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—CD36—atherosclerosis	6.93e-06	5.7e-05	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—APOA1—atherosclerosis	6.93e-06	5.7e-05	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—ABCA1—atherosclerosis	6.72e-06	5.52e-05	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—NOS3—atherosclerosis	6.7e-06	5.51e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—ABCG1—atherosclerosis	6.67e-06	5.49e-05	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—PTGS2—atherosclerosis	6.67e-06	5.48e-05	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—MTHFR—atherosclerosis	6.63e-06	5.45e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—SERPINE1—atherosclerosis	6.57e-06	5.4e-05	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—MTHFR—atherosclerosis	6.57e-06	5.4e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—NAMPT—atherosclerosis	6.56e-06	5.39e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—LIPC—atherosclerosis	6.52e-06	5.36e-05	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—PPARA—atherosclerosis	6.5e-06	5.34e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—APOC3—atherosclerosis	6.48e-06	5.33e-05	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—PPARA—atherosclerosis	6.45e-06	5.3e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—LDLR—atherosclerosis	6.44e-06	5.29e-05	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—PTGS2—atherosclerosis	6.4e-06	5.26e-05	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—PIK3CG—atherosclerosis	6.33e-06	5.2e-05	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—AGT—atherosclerosis	6.3e-06	5.18e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—CETP—atherosclerosis	6.29e-06	5.17e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—FABP4—atherosclerosis	6.28e-06	5.16e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—LCAT—atherosclerosis	6.28e-06	5.16e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—NOS3—atherosclerosis	6.27e-06	5.16e-05	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—AGT—atherosclerosis	6.24e-06	5.13e-05	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	6.18e-06	5.08e-05	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—APOE—atherosclerosis	6.17e-06	5.07e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—APOA4—atherosclerosis	6.16e-06	5.06e-05	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—PTGS2—atherosclerosis	6.13e-06	5.04e-05	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—APOE—atherosclerosis	6.12e-06	5.03e-05	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—CAV1—atherosclerosis	6.11e-06	5.02e-05	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—PPARG—atherosclerosis	6.11e-06	5.02e-05	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—APOA1—atherosclerosis	6.1e-06	5.01e-05	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—CAV1—atherosclerosis	6.06e-06	4.98e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—CYP7A1—atherosclerosis	6.05e-06	4.97e-05	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—APOA1—atherosclerosis	6.05e-06	4.97e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—SCARB1—atherosclerosis	6.03e-06	4.95e-05	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—INS—atherosclerosis	5.99e-06	4.92e-05	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—HMOX1—atherosclerosis	5.77e-06	4.74e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—PTGS2—atherosclerosis	5.74e-06	4.72e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—HMGCR—atherosclerosis	5.69e-06	4.68e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—CYP27A1—atherosclerosis	5.59e-06	4.6e-05	CbGpPWpGaD
Vincristine—ABCB1—Transmembrane transport of small molecules—ALB—atherosclerosis	5.58e-06	4.58e-05	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—PIK3CG—atherosclerosis	5.57e-06	4.58e-05	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—APOB—atherosclerosis	5.52e-06	4.54e-05	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—PIK3CG—atherosclerosis	5.52e-06	4.54e-05	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—ALB—atherosclerosis	5.49e-06	4.51e-05	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—PPARG—atherosclerosis	5.37e-06	4.42e-05	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—GSTM1—atherosclerosis	5.37e-06	4.42e-05	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—PPARG—atherosclerosis	5.33e-06	4.38e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—ALOX15—atherosclerosis	5.3e-06	4.36e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	5.3e-06	4.36e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	5.3e-06	4.36e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—APOA2—atherosclerosis	5.3e-06	4.36e-05	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—LPL—atherosclerosis	5.27e-06	4.33e-05	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—INS—atherosclerosis	5.27e-06	4.33e-05	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—NOS3—atherosclerosis	5.25e-06	4.32e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—ABCG5—atherosclerosis	5.24e-06	4.3e-05	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—INS—atherosclerosis	5.23e-06	4.29e-05	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—GPX1—atherosclerosis	5.15e-06	4.23e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—ABCA1—atherosclerosis	5.07e-06	4.17e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—LPA—atherosclerosis	5.06e-06	4.16e-05	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—CD36—atherosclerosis	5.01e-06	4.12e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—BGN—atherosclerosis	4.9e-06	4.03e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—APOA5—atherosclerosis	4.85e-06	3.99e-05	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—ALB—atherosclerosis	4.83e-06	3.97e-05	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—PTGS2—atherosclerosis	4.81e-06	3.95e-05	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—ALB—atherosclerosis	4.79e-06	3.94e-05	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—MTHFR—atherosclerosis	4.75e-06	3.9e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	4.67e-06	3.84e-05	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—PPARA—atherosclerosis	4.66e-06	3.83e-05	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—NOS3—atherosclerosis	4.62e-06	3.8e-05	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—NOS3—atherosclerosis	4.58e-06	3.77e-05	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—AGT—atherosclerosis	4.51e-06	3.71e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—ALOX5—atherosclerosis	4.51e-06	3.71e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—STAT3—atherosclerosis	4.48e-06	3.68e-05	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—APOE—atherosclerosis	4.42e-06	3.63e-05	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—CAV1—atherosclerosis	4.38e-06	3.6e-05	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—APOA1—atherosclerosis	4.37e-06	3.59e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—HMOX1—atherosclerosis	4.35e-06	3.58e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—MAPK3—atherosclerosis	4.28e-06	3.51e-05	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—PTGS2—atherosclerosis	4.23e-06	3.47e-05	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—PTGS2—atherosclerosis	4.19e-06	3.44e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—APOB—atherosclerosis	4.17e-06	3.43e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—TGFB1—atherosclerosis	4.15e-06	3.41e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—GSTM1—atherosclerosis	4.05e-06	3.33e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—NAMPT—atherosclerosis	4.04e-06	3.32e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—LIPC—atherosclerosis	4.02e-06	3.3e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—APOC3—atherosclerosis	3.99e-06	3.28e-05	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—PIK3CG—atherosclerosis	3.99e-06	3.28e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—LPL—atherosclerosis	3.98e-06	3.27e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—LDLR—atherosclerosis	3.97e-06	3.26e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—GPX1—atherosclerosis	3.88e-06	3.19e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—CETP—atherosclerosis	3.88e-06	3.19e-05	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—PPARG—atherosclerosis	3.85e-06	3.16e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—CD36—atherosclerosis	3.78e-06	3.11e-05	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—INS—atherosclerosis	3.78e-06	3.1e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—SCARB1—atherosclerosis	3.71e-06	3.05e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—MTHFR—atherosclerosis	3.58e-06	2.95e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—PPARA—atherosclerosis	3.52e-06	2.89e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—HMGCR—atherosclerosis	3.51e-06	2.88e-05	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—ALB—atherosclerosis	3.46e-06	2.85e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—AGT—atherosclerosis	3.4e-06	2.8e-05	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—AKT1—atherosclerosis	3.35e-06	2.76e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—APOE—atherosclerosis	3.34e-06	2.74e-05	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—NOS3—atherosclerosis	3.31e-06	2.72e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—CAV1—atherosclerosis	3.31e-06	2.72e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—APOA1—atherosclerosis	3.3e-06	2.71e-05	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—AKT1—atherosclerosis	3.21e-06	2.64e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—IL6—atherosclerosis	3.13e-06	2.57e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—ABCA1—atherosclerosis	3.13e-06	2.57e-05	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—AKT1—atherosclerosis	3.08e-06	2.53e-05	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—PTGS2—atherosclerosis	3.03e-06	2.49e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—PIK3CG—atherosclerosis	3.01e-06	2.47e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—PPARG—atherosclerosis	2.91e-06	2.39e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—AKT1—atherosclerosis	2.88e-06	2.37e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—INS—atherosclerosis	2.85e-06	2.34e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—HMOX1—atherosclerosis	2.68e-06	2.2e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—ALB—atherosclerosis	2.61e-06	2.15e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—APOB—atherosclerosis	2.57e-06	2.11e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—NOS3—atherosclerosis	2.5e-06	2.05e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—GSTM1—atherosclerosis	2.5e-06	2.05e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—LPL—atherosclerosis	2.45e-06	2.02e-05	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—AKT1—atherosclerosis	2.42e-06	1.98e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—GPX1—atherosclerosis	2.39e-06	1.97e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—CD36—atherosclerosis	2.33e-06	1.91e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—PTGS2—atherosclerosis	2.29e-06	1.88e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—MTHFR—atherosclerosis	2.21e-06	1.81e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—PPARA—atherosclerosis	2.17e-06	1.78e-05	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—AKT1—atherosclerosis	2.13e-06	1.75e-05	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—AKT1—atherosclerosis	2.11e-06	1.73e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—AGT—atherosclerosis	2.1e-06	1.72e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—APOE—atherosclerosis	2.06e-06	1.69e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—CAV1—atherosclerosis	2.04e-06	1.67e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—APOA1—atherosclerosis	2.03e-06	1.67e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—PIK3CG—atherosclerosis	1.86e-06	1.52e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—PPARG—atherosclerosis	1.79e-06	1.47e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—INS—atherosclerosis	1.76e-06	1.44e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—ALB—atherosclerosis	1.61e-06	1.32e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—NOS3—atherosclerosis	1.54e-06	1.27e-05	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—AKT1—atherosclerosis	1.52e-06	1.25e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—PTGS2—atherosclerosis	1.41e-06	1.16e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—AKT1—atherosclerosis	1.15e-06	9.44e-06	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—AKT1—atherosclerosis	7.08e-07	5.82e-06	CbGpPWpGaD
